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HISTORY:  
Tuberculosis has been present in humans since antiquity. The origins of the disease 
are in the first domestication of cattle. Skeletal remains show prehistoric humans (4000 BC) 
had TB, and tubercular decay has been found in the spines of Egyptian mummies from 3000-
2400 BC. There were references to TB in India around 2000 BC.  
Around 460 BC, Hippocrates called the disease phthisis (consumption), emphasizing 
the dramatic aspect of general wasting associated with chronic untreated cases. He described 
that diarrhea in a patient with phthisis is a mortal symptom. 
Around 200 A.D., the Roman doctor Claudius Galen recognized the consumption as 
incurable and recommended a treatment plan of fresh air, rest, and good food.  
Results of postmortem examination on Louis XVIII evidenced an ulcerative lesion 
with intestinal perforation associated with a cavitary lung disease.  
 In 1546, Girolamo Tracastoro explained the contagious nature of TB in his book “De 
Morbis Contagiosis”.  He wrote that bed sheets and clothing could contain contagious 
particles.  
In 1679, Franciscus de la Boe, more commonly known as Dr. Silvius, wrote the 
“Opera Medica”. He described the tubercles and characterized the infection’s course 
throughout the lungs and body of infected patients providing clear descriptions detailing the 
tuberculous cavities and tuberculous lymph nodes as well. 
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In 1720, an English physician, Benjamin Marten, was responsible for the first theory 
regarding Mycobacterium tuberculosis as “wonderfully minute living creatures”.  He wrote 
the book “A New Theory of Consumption” regarding his views. 
In 1761, Austrian Leopold Avensbrugger wrote a book on tuberculosis about the 
clinical symptoms and different pathologies of the disease.   
In 1782, a physicist named Graumann proved conclusively that syphilis and 
tuberculosis were not the same disease. 
In1810, a London physician, Carmichael, wrote a dissertation demonstrating that 
cattle tuberculosis is transmitted to humans through infected meat and milk. 
In1854, Hermann Brehmer who suffered from TB himself theorized that TB was 
treatable after his doctor recommended that he move to a more temperate climate, like the 
Himalayas. After recuperating there, he returned home healthy and cured.  He built the first 
sanatorium where patients could recuperate under the influences of fresh air and healthy 
eating habits.   
In 1865, a French army physician, Jean-Antoine Villemin demonstrated the 
transmission of TB from humans to cattle to rabbits. He theorized that the disease was caused 
by a certain organism and did not arise from spontaneous generation as previously believed.   
In March 24, 1882 Robert Koch identified and described the bacillus-causing 
tuberculosis, Mycobacterium tuberculosis. He received the Nobel Prize in physiology or 
medicine in 1905 for this discovery. Koch did not believe that bovine (cattle) and human 
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tuberculosis were similar, which held back the recognition of infected milk as a source of 
infection. Later, this source was eliminated by the pasteurization process. Koch announced a 
glycerin extract of the tubercle bacilli as a "remedy" for tuberculosis in 1890, calling it 
'tuberculin'. It was not effective, but was later adapted by von Pirquet in a test for pre-
symptomatic tuberculosis. 
BCG (Bacillus of Calmette and Guerin) was developed from attenuated bovine-strain 
tuberculosis by Albert Calmette and Camille Guerin in 1906. The BCG vaccine was first 
used on humans on July 18, 1921 in France. 
In 1890, an Italian doctor, Forlanini, created the first therapy for TB patients. He 
found that collapsing the lungs had positive effects on recovery from tuberculosis.   
In 1895, Wilhelm Konrad bon Rontgen used radiation to examine the progression and 
assess the severity of the illness in TB patients. 
In1920s, a treatise by Assmann cultivated the theory of reinfection. 
Finally, in 1943, Selman A. Waksman developed the antibiotic Streptomycin. The 
first time it was administered to a live, human patient was November 20, 1944.  The 
progression of the disease was halted, the bacteria were later absent from the sputum, and the 
patient was fully healed.  In the years following, more TB drugs were discovered.  
Hopes that the disease could be completely eliminated have been dashed since the 
rise of drug-resistant strains in the 1980s. The resurgence of tuberculosis resulted in the 
declaration of a global health emergency by the World Health Organization in 1993. 
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INTRODUCTION:  
Tuberculosis (TB) remains the single largest infectious disease causing high mortality 
in humans, leading to 3 million deaths annually, about five deaths every minute. 
Approximately 8-10 million people are infected with this pathogen every year12. In India, 
there are about 500,000 deaths occurring annually due to TB13, with the incidence and 
prevalence being 1.5 and 3.5 millions per year. 
Approximately two billion individuals globally are infected with Mycobacterium 
tuberculosis, yet only 10% develop clinical tuberculosis 1.There was a surge of tuberculosis 
in mid-1980s in developed countries which may be due to multiple factors like infection with 
human immunodeficiency virus (HIV), immunosuppression with prolonged steroid therapy, 
immigration from countries with high prevalence of tuberculosis, and social problems such 
as poverty, homelessness, and drug abuse 2, 3. 
Tuberculosis continues to be a major health problem in India 4, 5. Deaths due to 
tuberculosis accounts to around 50/100,000 population. Forty percent of the cases in India 
contract tuberculosis by the age of 6 years and 80% by the age of 16 years 6. The incidence of 
tuberculosis is also increasing in Western countries 7, 8, 9. Poor socio economic status, poor 
sanitation and recent upsurgence of HIV infection enhance the susceptibility to tuberculosis 
in India. The exact prevalence of intestinal tuberculosis in India is not known.  
Several susceptibility-associated genetic polymorphisms have been proposed to 
explain differential susceptibility to tuberculosis (TB) progression in different populations. 
Though several gene polymorphisms have been associated with susceptibility or resistance to 
TB in different ethnic populations, only few of these genetic associations have shown to have 
functional effect on the containment by the host immune system. 
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REVIEW OF LITERATURE: 
Intestinal tuberculosis (ITB) was common in the early 20th century. It was responsible 
for most cases of small intestinal obstruction and stricture. There was a decline in ITB cases 
in the middle of the century in developed countries which was caused by 1) an increased 
standard of living 2) pasteurization of milk 3) control of bovine tuberculosis through 
slaughter of reactive animals and 4) the introduction of antituberculous chemotherapy in the 
1950s. 
Gastrointestinal tract (GIT) is a common location for tuberculosis infection and is the 
sixth most frequent site of extra pulmonary involvement. Intestinal tuberculosis still remains 
the most common granulomatous disease of the bowel in India 10, 11. Intestinal tuberculosis is 
an important cause of morbidity in the Indian population, especially because the diagnosis is 
often delayed due to non-specific nature of its signs and symptoms.  
The incidence in hospital admissions for ITB has been reported to be 0.8%4. In India, 
TB is responsible fir 7% of hospital admissions for intestinal obstructions and 6% of 
perforations21. Any segment of the GIT can be involved by tuberculosis, but the ileocecal 
region is the most commonly involved part of the tract, noted in up to 90% of cases with 
intestinal tuberculosis14, 15, 29, 30. In India, the organism isolated from all intestinal lesions has 
been Mycobacterium tuberculosis and not Mycobacterium Bovis 16,17,18,19 .In Bhansali’s 
series4, including 196 patients with gastrointestinal tuberculosis, ileum was involved in 52% 
and cecum in 51%  of  cases. Of the 300 patients in a study, ileocecal involvement was 
present in 54% of cases20. The frequency of bowel involvement declines as one proceeds 
both proximally and distally from the ileocecal region. 
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ITB is thought to result from swallowed organisms (infected sputum in active 
pulmonary tuberculosis or ingestion of contaminated milk) that directly penetrate the 
intestinal mucosa. Hematogenous spread (active pulmonary tuberculosis, miliary TB, or 
silent bacteremia during primary phase of TB) and direct extension from adjacent organs can 
also occur. Although any area of the GIT can be involved, the ileocaecal region is involved in 
approximately 75% of cases and studies in India have suggested that approximately 20% of 
the patients may have associated pulmonary involvement 22. It has been estimated that only 
10% of persons infected with Mycobacterium tuberculosis will ever develop clinical disease. 
Of the total number of patients with TB, only about 1% will have intestinal disease.   
Socioeconomic and environmental factors have long been known to influence the 
occurrence of tuberculosis in a community. A survey carried out in Wardha district 
(Maharashtra) is the only source of survey data (unpublished) linking tuberculosis in the 
community to socio-economic criteria 23. The prevalence rates in the survey had depended on 
literacy (lowest in the graduates and highest among the illiterates) and present employment 
(highest among the professionals, followed by cultivators and agricultural labour). These had 
also depended on income, living standard (those living in “Kutcha” houses had a higher 
prevalence than “pucca” house dwellers). Of the total cases in women, 48 percent were 
among those unemployed (include housewives). For all demographic variables, rates in 
female were less than those in males.  
As per Dholakia 24, evidence is lacking to assume a differential prevalence rate of 
tuberculosis among workers than among non-workers. Of the ‘workers’ group, estimated to 
be suffering from tuberculosis in India, about 52 percent were in the age group 15- 44 years. 
In this age group, women constitute about 40 percent and 17.9 percent of the workers with 
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tuberculosis in the urban and rural areas respectively. There was much lower proportion of 
women among workers with tuberculosis in higher ages, especially in the urban areas. In the 
Wardha survey 23, the urban professionals and rural service workers, who had a higher 
prevalence, had a low proportion of the female population in them, and had consequently 
accounted for a small proportion of the total cases among females. The extent of tuberculosis 
morbidity in the males in the economically active age and in females in the reproductive age 
marks it out as a priority among the public health problems in India. 
The available literature strongly suggests the possible role of genetic factors in the 
control of host responses to Mycobacterium tuberculosis (M.TB) 25, 26. Stead 27, has proposed 
that susceptibility to infection with M. TB has changed from being the norm of all humans to 
being an infection of certain population as a result of natural selection of resistance among 
ancestors who came in contact with the bacterium and survived the illness during the 
preantibiotic era. Distinct environmental and natural selective factors have likely resulted in 
population – specific immunogenetic adaptations to clinical tuberculosis. 
Convincing evidence exists from twin studies that host genetic factors are important 
in determining susceptibility to the infection. Kallmann and Reisner28 found an appreciably 
high concordance of pulmonary TB in monozygotic than dizygotic twins. Also the 
aggregation of pulmonary tuberculosis in families emphasizes the importance of heredity. 
The different manifestations of infection with M.TB reflect the balance between the 
bacilli and host defense mechanisms. Traditionally, protective immunity to tuberculosis has 
been ascribed to T-cell-mediated immunity, with CD4+ T cells playing a crucial role. Recent 
immunological and genetic studies support the long-standing notion that innate immunity is 
also relevant in tuberculosis.  
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There are several evidences to suggest that the production of the human leukocyte 
antigen (HLA) system, the major histocompatibility complex of humans, have an important 
function in controlling the cellular immune response to infectious agents31. Though cellular 
immunity in TB is regulated by HLA system, the exact role of HLA –DR genes on both the 
development and course of TB, as well as cellular and humoral immune response remains 
unknown. It is possible that the gene products are involved in the activation of T helper and 
inducer cells rather than in subsequent T-cell activation of B cells. Singh et al 32 showed that 
the DR2 antigen had a preferential tendency to be transferred from TB parents to their 
affected children. In a group of pulmonary TB patients from North India, he found that TB 
patients had an increased frequency of DR2 antigen and a marked decrease of DRW6 in 
comparison to healthy subjects. In a group of pulmonary TB patients from South India, 
Brahmajyothi V et al 33 noted that the frequencies of HLA-A10 and B8, but not DR2 were 
greater in control subjects. Hence DR2 may be involved in the pathogenesis of advanced 
pulmonary tuberculosis. The MHC genes may be physically close to the chromosome region 
that carries a gene conferring susceptibility or resistance to a particular disease. This 
association may explain the lack of complete association and geographic variation, due to 
linkage disequilibrium. Though HLA –DR2, DQ1 and their subtypes are significantly 
associated with the susceptibility to tuberculosis, and they may not be the sole genetic 
markers predisposing to tuberculosis suggesting that non-HLA genes may have a role in 
infection. 
M.TB is an intracellular parasite and cell mediated immunity is crucial for 
containment of infection34. After macrophage stimulation by mycobacterial infection, the 
secretion of TNF-α, interleukin-12, and possibly other factors by macrophages promotes 
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interferon-γ secretion by natural killer cells, differentiation of antigen-driven CD4+ T cells 
into interferon-γ producing Th1 cells, and activation of these Th1 cells to secrete interferon-γ 
and possibly other macrophage-activating factors35. Secretion of interferon-γ, in turn, results 
in macrophage secretion of TNF-α; enhanced antigen presentation, activation of macrophage 
mycobactericidal mechanisms such as nitric oxide production; and impaired proliferation of 
interleukin-4–secreting Th2 cells. 
Interferon-γ induces cellular activation by binding to a receptor complex consisting of 
at least two subunits: the interferon-γ binding subunit (interferon-γ receptor 1) and a 
chromosome 21–encoded transmembrane accessory factor (interferon-γ receptor 2). Both 
components of the receptor are thought to be required for normal signal transduction. Binding 
of interferon-γ induces dimerization of the interferon-γ receptor 1, which subsequently 
associates with interferon-γ receptor 2. Interferon-γ interacts with both interferon-γ receptor 1 
and interferon-γ receptor 2 during the process of association of the two-receptor proteins36. 
The Janus protein kinases Jak 1 and Jak 2 are associated with the intracellular domains of 
interferon-γ receptor 1 and interferon-γ receptor 2, respectively, and are brought together and 
activated by phosphorylation by the binding of interferon-γ to the receptor complex. This 
results in the phosphorylation of tyrosine at position 457 of the interferon-γ receptor 1 chain 
and produces a binding site for Stat 1 α (signal transduction and activation of transcription 
protein), leading to the phosphorylation, homodimerization, and subsequent dissociation of 
Stat 1α from the interferon-γ –receptor complex. The Stat 1α dimer translocates to the 
nucleus and interacts with  γ− activation sequences in the promoter regions of interferon-γ –
inducible genes, resulting in their transcription. 
 10
Activation of infected macrophages by interferon-gamma (IFN-γ) derived from T 
cells and natural killer cells are the principal antimycobacterial effector mechanisms. The 
importance of IFN-γ in human mycobacterial immunity was established by the identification 
of mutations in the gene encoding the IFN-γ receptor ligand binding chain as a cause of 
susceptibility to mycobacterial infection 37, 38. 
Recently several studies have shown that genes coding for different cytokines may 
affect host susceptibility to tuberculosis. Interferon-gamma (IFN-γ) is a proinflammatory 
Th1-type cytokine produced by T cells that appears to be necessary for the containment of 
mycobacterial infections. IFN-γ knockout mice were found to be highly susceptible to 
infection with M.TB. A recent study39demonstrated association between the (+874 A /T) 
polymorphism in the IFN-γ  gene and pulmonary TB, with subjects lacking the T allele was 
found to be at risk for pulmonary and meningeal tuberculosis. In a Spanish population, 
patients who were homozygous for the (+874A) allele of IFN-γ had a 3.75 fold increased risk 
of developing compared to healthy controls64. Reports have shown that a complete deficiency 
of interferon-γ receptor 1 may lead to BCG infection in vaccinated children or to atypical 
mycobacterial infection in unvaccinated persons38.  
Although IFN-γ production may vary among subjects, some studies suggest that IFN-
γ levels are depressed in patients with active TB 40, 41. In a study comparing the immune 
response to pre and post- BCG vaccination, it was seen that BCG had little effect in driving 
the immune response towards IFN-γ and a protective Th1 response42. In a study done to 
determine whether the effect of balance of T cell cytokines during initial stages of infection 
on clinical manifestations with M. TB in children, it was found that IFN-γ production was 
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most severely depressed in patients with moderately advanced and far advanced pulmonary 
disease and in malnourished patients though production of IL-12, IL-4 and IL-10 was similar 
in TB patients and healthy tuberculin reactors. Hence it is found that polymorphisms in the 
genes of these cytokines have functional significance43.  
Several polymorphic-derived deletions and point mutations of the mannose–binding 
lectin (MBL) 44-48, human analogue of the murine natural resistance associated macrophage 
protein 1 (NRAMP1) gene 49-53, the vitamin D receptor (VDR) gene 54-55, the interleukin -1 
(IL -1 α and ß) 56-58, IL -1 receptor antagonist (IL-1RA) 58,59,60, IL-10 56,61, IL -12 receptor 
antagonist (IL-12R) 62, tumor necrosis factor- alpha and beta (TNF-α and ß) 56,63, interferon-γ 
39,64and interferon-γ receptor 138 genes have been associated with susceptibility or resistance 
to TB in  different ethnic groups. Only few of these genetic associations have been shown to 
have relevant functional impact on the containment of the bacteria by the host immune 
system.  
Besides genetic differences in Th1/Th2 responses, conditioning of the mucosal 
immune system in childhood may be important in determining susceptibility to ITB. It has 
been postulated that helminthic infections (associated with less domestic hygiene) may 
stimulate a Th2-type immune reaction, down-regulate IFN-γ, and increase susceptibility to 
tuberculosis 65, 66. 
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Association of important candidate gene variants of HLA and non-HLA genes with the 
susceptibility or resistance to pulmonary tuberculosis in Indian population72 
 
Candidate genes Effect Reference 
HLA 
HLA-DR2 
 
Susceptibility 
 
32,33,73 
Sub-type 
-DRB1 * 1501, * 1502 
-DRB1 * 1501 
 
Susceptibility 
Susceptibility 
 
74 
75.76 
HLA-DQ1 
- DQB1*0601 
Susceptibility 
Susceptibility 
73.75 
75 
HLA-DP 
-DPB1*02 
Susceptibility 75 
Haplotype: 
DRB1and1501- DQB1*0601 
DRB1 * 11(5) 
DRB1 * 10 
DQB1*0501 
 
Susceptibility 
Resistance 
Resistance 
Resistance 
 
75 
75 
75 
75 
Non-classical HLA  
Transporter Associated with Antigen 
Processing (TAP) gene TAP 2 and 
DR2. 
Susceptibility 77 
Non-HLA 
Functional mutants Homozygotes to 
Mannose 
Binding Lectin (MBL) gene (codon 
52,54 and 57) 
- Heterozygotes of MBL codon 
57 
Vitamin D receptor (VDR) gene 
variants (Bsml, Apal, TaqI and FokI) 
NRAMP1 [(CA) n 823C/T, TGTG+/del 
and D543N G/A] 
 
Susceptibility 
 
 
 
Resistance to bacteriological 
relapse 
Differential susceptibility and 
resistance in males and females 
No association with 
susceptibility or resistance 
 
47 
 
 
 
47 
 
60,78 
 
79 
Cytokine gene 
TNF- α  -238, -308 
TNF- ß 
 
No association 
No association 
 
63 
63 
Haplotypes 
HLA-B17- TNF-α -238/A 
HLA-B17- TNF-α -308/2 
HLA-B17- TNF- ß -2 
 
Associated with bacteriological 
relapse 
 
63 
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Tuberculosis in HIV:  
  
Extrapulmonary disease is more common in patients with AIDS; 50% of the AIDS 
patients with tuberculosis have extrapulmonary involvement compared to only 10-15% of 
non-HIV tuberculosis patients 67. While 10 percent of those infected with TB will progress to 
active disease over their life times, those who are co-infected with both TB and HIV on the 
other hand progress rapidly, at the rate of 10 percent annually and about 60 percent in their 
life time. The pathogenesis of TB can be altered by HIV either through reactivation of latent 
tuberculosis infection to active disease (more common) or by causing rapid progression from 
recent infection with M. TB to tuberculosis disease. With progression of HIV infection, 
CD4+ T-lymphocytes decline in number and function. The immune system is therefore, less 
able to prevent the growth and local spread of M.TB. As a result, disseminated and extra-
pulmonary disease is more commonly seen. Nevertheless, pulmonary TB is still the most 
common form of TB even in HIV infected patient; pulmonary involvement can occur in 70-
90 percent of all patients with TB 68. 
Tuberculosis may precede the diagnosis of Acquired immunodeficiency syndrome 
(AIDS) by few months and the disease may be severe and progress rapidly in AIDS and vice 
versa 69, 70. Multidrug resistant TB is more common in patients with AIDS71.The risk of 
tuberculosis infection progressing to active tuberculosis is estimated to be 8 percent per year 
in an HIV positive person, as opposed to 10 percent life time risk in an immunocompetent 
person, infected with tuberculosis (non-HIV) 68. 
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PATHOPHYSIOLOGY:  
The pathophysiology of intestinal tuberculosis has been attributed to four 
mechanisms80: 1) swallowing of infected sputum in patients with active pulmonary TB; 2) 
hematogenous spread from active pulmonary or milary TB; 3) ingestion of contaminant milk 
or food; 4) contiguous spread from adjacent organs. After the tubercle bacillus enters the 
gastrointestinal tract, it traverses the mucosa to lodge in the submucosa. There, the presence 
of the bacillus induces inflammatory changes, including serosal and submucosal edema, 
cellular infiltration, and lymphatic hyperplasia. Eventually appearance of granulomas causes 
small papillary mucosal elevations81. Lymphangitis, endarteritis, and fibrosis ensue which 
lead to mucosal ulceration, caseation necrosis and narrowing of intestinal lumen82. Regional 
lymph node involvement occurs by lymphatic spread.  
In a review of 596 patients with abdominal TB3, the highest incidence of TB was 
noted in the GIT and in the peritoneum, followed by mesenteric lymph nodes. Within the 
GIT, the ileocecal area was the most common site of involvement. Infact, disease of the 
jejunoileum and ileocecal areas together comprised > 75% of cases, with the disease in the 
colon was found in 12% of the cases 83-86.The predilection of the bacillus for the ileo-cecum 
is attributed to three factors: 1) relative physiologic stasis of the area 2) the high rate of 
absorption with more complete digestion; and 3) the abundance of lymphoid tissue in 
ileocecal region.  
Pathology:  
Hoon et al 87originally classified the gross morphological appearance of the 
involved bowel into ulcerative, ulcerohyperplastic and hyperplasic varieties. Tandon and 
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Prakash 88 described the bowel lesions as ulcerative and ulcerohypertrophic types. 
Ulcerative form has been found more often in malnourished adults, while 
hypertrophic form is classically found in relatively well nourished adults. The bowel wall is 
thickened and the serosal surface is studded with nodules of variable size. These ulcerative 
and stricturous lesions are usually seen in the small intestine. In the less common 
hypertrophic form, inflammatory response and reactive tissue produce a multinodular 
mucosal pattern resembling neoplastic masses. The ulcero-hypertrophic pattern, most 
commonly seen in ileo-cecal region may produce "cobblestone" appearance 14, 88, 89. The 
patient often presents with a right iliac fossa lump constituted by the ileocecal region, 
mesenteric fat and lymph nodes.  
Adjacent tuberculous adenitis can cause colonic traction diverticula with narrowing, 
local fixation, and sinus tract development 14. Other characteristics of tubercular intestinal 
lesions include increased mesenteric fat and mesenteric adenopathy with caseation, which 
grossly resemble Crohn’s disease. Rarely colonic TB can present as diffuse tuberculous 
colitis which must be differentiated from inflammatory bowel disease (IBD), because steroid 
treatment can be lifesaving in IBD and lethal in ITB 90. 
Tuberculous granulomas are initially formed in the mucosa or the Peyer’s patches. 
These granulomas are of variable size and characteristically tend to be confluent, in contrast 
to those in Crohn’s disease. The presence of central caseation is the hallmark of granulomas 
caused by tuberculosis 88. Granulomas are often seen just beneath the ulcer bed, mainly in the 
submucosal layer. Submucosal oedema or widening is inconspicuous. Tubercular ulcers are 
relatively superficial and usually do not penetrate beyond the muscularis 88. They may be 
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single or multiple, usually 3-6 mm in diameter, with an irregular margin and usually present 
as transverse lesion parallel to each other. This orientation is related to the arrangement of the 
submucosal lymphatic structures except when a Peyer’s patch alone is involved resulting in a 
longitudinal orientation .The intervening mucosa is usually uninvolved. These ulcers are 
usually transversely oriented in contrast to Crohn’s disease where the ulcers are longitudinal 
or serpiginous 91. These circumferential 'girdle ulcers’, usually cicatrize during healing and 
form strictures. Occlusive arterial changes may produce ischemia and contribute to the 
development of strictures92. Endarteritis also accounts for the rarity of massive bleeding in 
cases of intestinal tuberculosis. Shah et al 93 correlated findings on barium studies and 
superior mesenteric angiography in 20 patients. Angiograms were abnormal in all and 
showed arterial encasement, stretching and crowding of vessels, and hypervascularity. 
Patients with strictures had occlusion of the vasa recta, while ulcerated lesions had 
hypervascularity. In long-standing lesions there may be variable degree of fibrosis of the 
bowel wall, which extends from submucosa into the muscularis. Many sections may show 
only non-specific chronic inflammation and no granulomas. Pulimood 94et al., described 
histological changes characteristic of TB and CD. They suggested that multiple (mean 
number of granulomas per section: 5.35), large (mean widest diameter: 193µm), confluent 
granulomas often with caseation necrosis are characteristic of TB. Other features were ulcers 
lined by conglomerate epithelioid histiocytes and disproportionate submucosal inflammation. 
The features characteristics of Crohn’s disease (CD) were infrequent (mean number of 
granulomas per section: 0.75), small (mean widest diameter: 95µm) granulomas, 
microgranulomas (defined as poorly organized collections of epithelioid histiocytes), focally 
enhanced colitis, and a high prevalence of chronic inflammation, even in endoscopically 
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normal appearing areas. They also described that granulomas larger than 400µm in maximum 
dimension, more than four sites of granulomatous inflammation per site, caseation, a band of 
epithelioid histiocytes in ulcer bases and location of granulomas in the caecum favored a 
diagnosis of TB compared to CD95. 
Mesenteric lymph nodes may be enlarged matted and may caseate. Characteristic 
granulomas may be seen only in the mesenteric lymph nodes. This is especially common in 
patients who have taken antitubercular therapy for some time. The reverse, i.e., the presence 
of granulomas in the intestine and no granulomas in the draining lymph nodes is rare87. 
Clinical features:  
ITB is predominantly a disease of young adults. Two-thirds of the patients are 21-40 
years old 96, 97 and the mean age of patients is 30-40 years96. Although some studies mention 
female preponderance, it seems that the disease affects both sexes equally. Intestinal lesions 
are present in only 10% of cases of abdominal TB in children97. ITB is characterized by 
different modes of presentation, viz acute (no previous history of obstruction), chronic or 
acute on chronic (episode of acute obstruction with history of sub acute obstruction).  
Most patients have constitutional symptoms of fever with evening rise (40-70%), 
abdominal pain (80-95%), diarrhea (11-20%), constipation, alternating constipation and 
diarrhea, weight loss (40-90%), anorexia, malaise and night sweats. Pain can be either 
colicky due to luminal compromise, or dull and continuous when the mesenteric lymph nodes 
are involved. Some patients, particularly those with miliary tuberculosis, may have features 
of toxemia 20with high fever, tachycardia, anemia and leucocytosis.  Patients in India 
probably because of the social stigma still attached to the disease rarely reveal a family 
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history of TB, which is reported in about one –third of patients in UK19, 84. Peripheral lymph 
nodes (cervical or axillary) may be involved in 3-10% of the patients 17,22,97,98. Other clinical 
features depend upon the site, nature and extent of involvement and are detailed below: 
Esophageal tuberculosis 
Tuberculosis of the esophagus is a rare and constitutes 0.2% of cases of abdominal 
tuberculosis99. The relative rarity is thought to be due to rapid transit time and the vertical, 
smooth stratified squamous epithelium. Esophageal involvement occurs with a secondary 
spread from adjacent sites such as lymph nodes, pulmonary, and vertebral tuberculosis 100,101 
or retrograde lymphatic spread 100.  Primary esophageal tuberculosis is very unusual102. 
Midoesophagus is the most common site of involvement. Rarely, upper one-third may be 
involved by direct extension from pharynx and larynx. The commonest presenting symptoms 
are dysphagia , weight loss , retrosternal pain  and coughing on swallowing .The disease 
usually mimics esophageal carcinoma and extra esophageal focus of tuberculosis may not be 
evident 103.Rarely , there may be massive hematemesis from an aortoesophageal fistula due 
to tuberculous aortitis 104. 
Barium examination demonstrates extrinsic compression of the enlarged lymph nodes 
to the esophagus, esophago-bronchial fistula, sinus tract formation, mucosal irregularity, and 
ulceration 105. Computed tomography is a more reliable method to determine full extent of 
the disease into mediastinum 105, 106. 
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Tuberculosis of stomach 
Gastric involvement is very rare and constitutes around 0.2-1% of abdominal 
tuberculosis. It occurs with a secondary spread from adjacent lymph nodes or hematogenous 
route. The infrequent involvement of the stomach is due to the relative resistance of the 
gastric mucosa, high acid content in stomach, lack of lymphoid tissue in the stomach and 
rapid passage of gastric contents into the intestines. Any part of the stomach can be involved 
but the usual sites are lesser curvature and antrum99. Lesions may be ulcerative or 
hypertrophic infiltrative type. 
Gastro duodenal tuberculosis may mimic peptic ulcer disease with a shorter duration 
of history and non-response to anti -secretary therapy107. Constitutional symptoms may be 
present in affected individuals. Hematemesis is a common presentation. It may also simulate 
gastric carcinoma. Chowdhary et al 108 reported the rare concurrence of carcinoma and 
tuberculosis of stomach in the same patient. Primary gastric tuberculosis has also been 
reported 99.Patient may present with features of outlet obstruction due to inflammatory 
changes, fibrosis, or enlarged lymph nodes 109,110. Caseating granulomas seen on microscopy 
are usually located in mucosa and submucosa, but rarely extend to the muscularis layer. This 
may the reason for rarity of free perforation in gastric tuberculosis99. 
Radiological features are nonspecific, mimicking the signs of benign ulcer in the 
ulcerative form of tuberculosis, and of malignancy in the hypertrophied form. Computed 
tomography (CT) is very important to delineate the regional lymphadenopathy.  
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Gastric tuberculosis should be differentiated radio graphically from gastric 
carcinoma, non-Hodgkin's lymphoma, syphilis, and sarcoidosis. Endoscopic biopsy is 
indicated to obtain the diagnosis. There is no specific picture of duodenal tuberculosis on 
endoscopy, and demonstration of granulomas or acid fact bacilli on endoscopic biopsy 
material is unusual. Because of the lack of accurate clinical diagnosis, most patients end up 
with surgical intervention, and the diagnosis is made by surgery.   
Tuberculosis of duodenum: 
Duodenal involvement is extremely rare, occurring in up to 0.2- 2% of the patients 
with ITB 111. It may present as duodenal obstruction with narrowing and sometimes fistula 
due to adjacent lymph nodes. Duodenal narrowing due to enlarged lymph nodes is 
recognized in the third or fourth part of duodenum.  
The largest published series of duodenal tuberculosis reported 30 cases from India 112. 
Most patients (73%) had symptoms of duodenal obstruction. In a majority of these cases 
obstruction was due to extrinsic compression by tuberculous lymph nodes, rather than by 
intrinsic duodenal lesion. The remainder (27%) had a history of dyspepsia and was suspected 
of having duodenal ulcers. Patient can present with hematemesis 113,114.Other reported 
complications by various authors are perforation 115, fistulae (pyeloduodenal, 
duodenocutaneous, blind) 115, excavating ulcers extending into pancreas116 and obstructive 
jaundice by compression of the common bile duct117. 
Barium studies reveal evidence of segmental narrowing. Duodenal strictures are 
usually short but can involve long segments of the duodenum. A matted mass containing 
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enlarged lymph nodes and thickened mesenteric root is demonstrated by US or CT118. There 
is no specific picture of duodenal tuberculosis on endoscopy, and demonstration of 
granulomas or acid fact bacilli on endoscopic biopsy material is unusual. Surgical bypass has 
been required in the majority of cases to relieve obstruction but successful endoscopic 
balloon dilatation (TTS balloon, Microvasive) of duodenal strictures has been reported by Vij 
et al119 in two cases. 
Tuberculosis of jejunum and ileum 
Jejunal or ileal involvement, except of the terminal ileum is rarely seen. Nonspecific 
changes are demonstrated on barium studies and CT 89.  
Tuberculosis of the appendix:  
In India, tuberculosis is found in 2.3 % of appendicectomies 120. It is usually 
secondary to tuberculosis elsewhere in the abdomen: local extension of the disease, 
lymphatic spread, or peritoneal disease. The rare primary disease of the appendix may 
present with perforation 121.  
 
Ileocecal tuberculosis: 
Colicky, midabdominal and/or right lower quadrant pain , distension, gurgling 
,vomiting, feeling of a ball of wind moving in the abdomen , and visible loops and peristalsis 
which are relieved spontaneously after passage of flatus reflects intermittent partial small 
bowel obstruction, is the presenting complaint in 90-100% of patients 80,122 . Abdominal 
examination may reveal no abnormality or a doughy feel. A well-defined, firm, usually 
mobile mass is often palpable in the right lower quadrant of the abdomen in 25-50 % of 
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cases. Associated lymphadenitis is responsible for the presence of one or more lumps which 
are mobile if mesenteric nodes are involved and fixed if para-aortic or iliac group of nodes 
are enlarged 4 .The most common complication is obstruction due to narrowing of the lumen 
by hyperplasic caecal tuberculosis, by strictures of the small intestine, which are commonly 
multiple, or by adhesions. Adjacent lymph nodal involvement can lead to traction, narrowing 
and fixity of bowel loops. In India, around 3 to 20 percent of all cases of bowel obstructions 
are due to tuberculosis 4,123,124. In a large series of 348 cases of intestinal obstruction, 
Bhansali and Sethna 123 found tuberculosis to be responsible for 54 (15.5%) cases; 33 cases 
were small bowel and 21 large bowel obstruction. Tandon et al 22 studied 186 patients over 5 
yr and observed a change in clinical profile with an increase in patients with more protracted 
course and subacute intestinal obstruction in recent years. 
Tuberculosis accounts for 5 to 9 percent of all small intestinal perforations in India,  
and is the second commonest cause after typhoid fever 125,126. Evidence of tuberculosis on 
chest X -ray and a history of subacute intestinal obstruction are important clues.  
Pneumoperitoneum may be detected on radiographs in only half of the cases. Tubercular 
perforations are usually single and proximal to a stricture 92. Acute tubercular peritonitis 
without intestinal perforation is usually an acute presentation of peritoneal disease but may 
be due to ruptured caseating lymph nodes 4,126. 
Malabsorption is a common complication. It is the most important cause of 
malabsorption syndrome in India, next to tropical sprue 4. In a patient with malabsorption, a 
history of abdominal pain usually suggests the diagnosis of tuberculosis 127. Pimparkar and 
Donde 128 studied 40 patients with malabsorption and divided them into those with and 
without bowel stricture. They performed glucose and lactose tolerance tests, D-xylose test, 
 23
faecal fat and Schillings test for B12 malabsorption and found them to be abnormal in 28, 22, 
57, 60 and 63 percent respectively in patients with stricture compared to 0, 0, 8, 25 and 30 
percent respectively without strictures. Tandon et al 129 also reported biochemical evidence of 
malabsorption in 75 percent of patients with intestinal obstruction and in 40 percent of those 
without it. The cause of malabsorption in ITB is postulated to be bacterial overgrowth in a 
stagnant loop, bile salt deconjugation, diminished absorptive surface due to ulceration, and 
involvement of lymphatics and lymph nodes. Minor rectal bleeding in ITB has been 
described frequently 130,131; however massive bleeding is a rare manifestation of the disease 
132-135. It has been suggested that intestinal TB increases the capillary vascularity, and small 
arteries undergo obliterative endarteritis that makes bleeding uncommon 136 
Segmental colonic tuberculosis:  
Segmental or isolated colonic tuberculosis refers to involvement of the colon without 
ileocecal region, and constitutes 9.2 percent of all cases of abdominal tuberculosis and 
around 15-20% of intestinal tuberculosis 137,138. It commonly involves the sigmoid, ascending 
and transverse colon 139. Multifocal involvement is seen in one third (28 to 44%) of patients 
with colonic tuberculosis 130,140.The median duration of symptoms at presentation is less than 
1 yr 131. Abdominal pain is the predominant symptom in 78-90 percent of patients and 
hematochezia occurs in less than one third 140,141. The bleeding is frequently minor and 
massive bleeding is less common. Singh et al 131 reported rectal bleeding in 31 percent of 
patients with colonic tuberculosis, and it was massive in 13 percent. Bhargava et al 142 
reported bleeding in 70 percent cases. Overall, tuberculosis accounts for about 4 percent of 
patients with lower gastrointestinal bleeding 92. The diagnosis is suggested by barium enema 
or colonoscopy. Tuberculosis is a great mimicker and the most important differential 
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diagnosis include Crohn’s disease, ulcerative colitis (in case of diffuse colitis), carcinoma of 
colon, amoeboma, Yersinia infection, gastrointestinal histoplasmosis, ischemic colitis, 
pseudomembranous colitis and periappendiceal abscess. The coexistence of colonic TB and 
colonic cancer has been described143. Colonic tuberculosis might be complicated by 
perforation causing peritonitis 144.  
Rectal and anal tuberculosis 
Rectal tuberculosis is rare 147 and may occur as isolated lesions. Clinical presentation 
of rectal tuberculosis is different from more proximal disease. Hematochezia is the most 
common symptom (88%) followed by constitutional symptoms (75 %) and constipation 
(37%) 141. The high frequency of rectal bleeding may be because of mucosal trauma caused 
by stool traversing the strictured segment. Digital examination usually reveals an annular 
stricture. The stricture is usually tight and of variable length with focal areas of deep 
ulceration. It is usually within 10 cm of the anal verge 131. Associated perianal disease is very 
rare. Excessive fibrosis associated with the rectal inflammation results in an increase in 
presacral space.  
Anal tuberculosis is less uncommon and has a distinct clinical presentation. Most anal 
and perianal lesions are ulcerative, although lupoid and verrucous forms have been described. 
There is an association with anorectal fistula 145 and perianal tuberculous abscess 149. 
Tubercular fistulae are usually multiple. Most ulcers are shallow with bluish undermined 
edges. Progression of the ulcers is usually slow. There may be associated inguinal 
lymphadenopathy 145.Biopsy should differentiate the lesions of Crohn’s disease, squamous 
cell carcinoma, Lymphogranuloma venereum and Syphilis. Dandapat et al 146 reported that 
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12 out of 15 multiple perianal fistulae were of tubercular origin, as compared to only 4 out of 
61 solitary perianal fistulae. Shukla et al 145 reported that in India, tuberculosis accounted for 
up to 14 percent of cases of fistula in ano. Anal discharge was present in all cases and 
perianal swelling in one third. Constitutional symptoms were not present in any patient 145. 
Anal tuberculosis is also seen in paediatric patients 148. 
 
Diagnosis and investigations:  
Despite a high index of suspicion, ITB can be difficult to diagnose. Symptoms are 
vague, signs are nonspecific and the disease closely mimics many other diseases. 
Paustian stated that atleat one of the following four criteria must be fulfilled to 
diagnose abdominal tuberculosis: (i) A positive culture from enteric, mesenteric or lymphatic 
tissue (ii) typical findings at surgery with histological evidence of tuberculosis in mesenteric 
nodes (iii) histological demonstration of caseating granuloma ;(iv) histological demonstration 
of acid fast bacilli in a lesion152. A fifth criterion defined by Logan 149 as indicating “probable 
tuberculosis” is a favorable response to antituberculous treatment of concurrent tuberculosis. 
These criteria are rarely present together153. These criteria must be considered and the 
diagnosis substantiated by adequate radiological and histopathological studies.  
Laboratory results can be nonspecific or normal. The most common abnormal 
laboratory finding is an elevated erythrocyte sedimentation rate (50-80%) 20, 97, 98. Mild 
anemia is also relatively frequent (50-80%) 20, 97, 98. Hypoalbuminaemia may suggest 
malnutrition or malabsorption84.  
Tuberculin skin test: A positive purified protein derivative (PPD) test is found in 70-
86% of patients71; however this test may has limited usefulness in immunosuppressed 
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patients. The test has a lower specificity for abdominal (77%) 153 than for pulmonary (84%) 
tuberculosis154. It doesn’t differentiate between active disease and previous sensitization by 
contact or vaccination.  
Radiological studies:  Chest X-ray: It is positive in only 25% of the patients 22. 
Evidence of tuberculosis in a chest X-ray supports the diagnosis but a normal chest X-ray 
does not rule it out. Chest X-ray may show evidence of active or healed tuberculosis. Sharma 
et al 151 studied 70 cases of abdominal tuberculosis and found evidence of active or healed 
lesions on chest X-ray in 32 (46%). X-rays were more likely to be positive in patients with 
ulcerative intestinal types and with acute complications 151. In Prakash’s series of 300 
patients, none had active pulmonary tuberculosis but 39 percent had evidence of healed 
tuberculosis10. 
Plain X-ray abdomen: Plain X -ray abdomen may show enteroliths, features of 
intestinal obstruction i.e., dilated bowel loops with multiple air fluid levels, evidence of 
ascites, perforation or intussusception. In addition, there may be calcified lymph nodes, 
calcified granulomas and hepatosplenomegaly. 
Small bowel barium meal: The following features may be seen: mucosal 
irregularity and rapid emptying (in ulcerative type); hyper segmentation of the barium 
column (“chicken intestine”), precipitation, flocculation and dilution of the barium (due to 
malabsorption); stiffened and thickened folds; luminal stenosis with smooth but stiff 
contours (“hour glass stenosis “), multiple strictures with segmental dilatation of bowel 
loops; and fixity and matting of bowel loops. 
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Barium enema: The following features may be seen: 
(i)  Early involvement of the ileocecal region manifesting as spasm and edema of the 
ileocecal valve. Thickening of the lips of the ileocecal valve and/or wide gaping of 
the valve with narrowing of the terminal ileum (“Fleischner” or “inverted umbrella 
sign”) are characteristic. 
(ii)  Fold thickening and contour irregularity of the terminal ileum, better appreciated 
on double contrast study. 
(iii)  “Conical caecum”, shrunken in size and pulled out of the iliac fossa due to 
contraction and fibrosis of the mesocolon. The hepatic flexure may also be pulled 
down.  
(iv)  Loss of normal ileocecal angle and dilated terminal ileum, appearing suspended from 
a retracted, fibrosed caecum (“goose neck deformity”). 
(v)  “Purse string stenosis” - localized stenosis opposite the ileocecal valve with a rounded 
off smooth caecum and a dilated terminal ileum. 
(vi)  “Stierlin ’s sign ” is a manifestation of acute inflammation superimposed on a 
chronically involved segment and is characterized by lack of barium retention in the 
inflamed segments of the ileum, caecum and variable length of the ascending colon, 
with a normal configured column of barium on either side. It appears as a narrowing 
of the terminal ileum with rapid emptying into a shortened, rigid or obliterated 
caecum. 
(vii)  “String sign” - persistent narrow stream of barium indicating stenosis. 
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Both Stierlin and String signs can also be seen in Crohn's disease and hence are not 
specific for tuberculosis. 
Barium studies are sensitive for ileocecal and colonic lesions 98. Tandon et al 22 
reported false-negative barium studies in 25% of patients. Radiological studies may not 
always differentiate ITB from Crohn’s disease and malignancy. 
Ultrasonography: 
Barium studies though accurate for intrinsic bowel abnormalities, do not detect 
lesions in the peritoneum. Ultrasound is very useful for imaging peritoneal tuberculosis. 
The following features may be seen, usually in combination 29. 
(i)  Intra -abdominal fluid, which may be free or loculated; and clear or complex (with 
debris and septae). Fluid collections in the pelvis may have thick septa and can mimic 
ovarian cyst. 
(ii)  “Club sandwich” or “sliced bread” sign is due to localized fluid between radially 
oriented bowel loops, due to local exudation from the inflamed bowel (interloop 
ascitis). 
(iii)  Lymphadenopathy may be discrete or conglomerated (matted). The echotexture is 
mixed heterogenous, in contrast to the homogenously hypoechoic nodes of 
lymphoma. Small discrete anechoic areas representing zones of caseation may be 
seen within the nodes. With treatment the nodes show a transient increase in size for 
3-4 weeks and then gradually reduce in size. Calcification in healing lesions is seen as 
discrete reflective lines. Both caseation and calcification are highly suggestive of a 
tubercular etiology, neither being common in malignancy related lymphadenopathy. 
(iv)   Bowel wall thickening is best appreciated in the ileocecal region. The thickening 
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is uniform and concentric as opposed to the eccentric thickening at the mesenteric 
border found in Crohn’s disease and the variegated appearance of malignancy. 
(v)  Pseudokidney sign - involvement of the ileocecal region, which is pulled up to a 
subhepatic position. 
Computed tomographic (CT) scan: 
            Ileocecal tuberculosis is usually hyperplasic and well evaluated on CT scan. In early 
disease there is slight symmetric circumferential thickening of caecum and terminal ileum. 
Later the ileocecal valve and adjacent medial wall of the caecum is asymmetrically 
thickened. In more advanced disease gross wall thickening, adherent loops, large regional 
nodes and mesenteric thickening can together form a soft tissue mass centered on the 
ileocecal junction 155. Mural stratification does not occur in any of the cases. In comparison, 
Crohn's disease has a uniform pattern of wall thickening, which is concentric or largely 
symmetrical, and ranges from 0.6 to 1.7 cm. Some of patients show mural stratification 
164.CT scan can also pick up ulceration or nodularity within the terminal ileum, along with 
narrowing and proximal dilatation. Other areas of small and large bowel involvement 
manifest as circumferential wall thickening, narrowing of the lumen and ulceration. In the 
colon, involvement around the hepatic flexure is common. Complications of perforation, 
abscess, fistula and obstruction are also seen. Although amebiasis may produce the typical 
shrunken cecum seen in tuberculosis, small bowel association is very rare with amebiasis. 
Cecal carcinoma is always limited by ileocecal valve162. 
Tubercular ascitic fluid is of high attenuation value (25-45 HU) due to its high 
protein content. Strands, fine septae and debris within the fluid are characteristic, but are 
better appreciated on ultrasonography 155. Thickened peritoneum and enhancing 
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peritoneal nodules may be seen. 
Mesenteric disease on CT scan is seen as a patchy or diffuse increase in density, 
strands within the mesentery, and a stellate appearance. Lymph nodes may be interspersed. 
Omental thickening is well seen often as an omental cake appearance. A fibrous wall can 
cover the omentum, developing from long standing inflammation and is called omental line. 
An omental line is less common in malignant infiltration 155. 
Caseating lymph nodes are seen as having hypodense centers and peripheral rim 
enhancement. Along with calcification, these findings are highly suggestive of tuberculosis. 
In tuberculosis the mesentery, mesenteric root, celiac, porta hepatis and peripancreatic nodes 
are characteristically involved, reflecting the lymphatic drainage of the small bowel. The 
retroperitoneal nodes (i.e., the periaortic and pericaval) are relatively spared, and are almost 
never seen in isolation, unlike lymphoma 155. 
 
Colonoscopy: 
                Colonoscopy with ileoscopy is an excellent tool to diagnose colonic and terminal 
ileal involvement, but is still often underutilized. Mucosal nodules of variable sizes (2 to 6 
mm) and ulcers in a discrete segment of colon, 4 to 8 cm in length are common. The nodules 
have a pink surface with no friability and are most often found in the caecum especially near 
the ileocaecal valve. Large (10 to 20 mm) or small (3 to 5 mm) ulcers are commonly located 
between the nodules. The intervening mucosa may be hyperemic or normal 130. Areas of 
strictures with nodular and ulcerated mucosa may be seen. Other findings are 
pseudopolypoid edematous folds, and a deformed and edematous ileocecal valve. Diffuse 
involvement of the entire colon is rare (4%), but endoscopically can look very similar to 
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ulcerative colitis. Lesions mimicking carcinoma have also been described130, 131,141. The 
ileocecal angle is distorted and often obtuse. Both sides of the ileocecal valve are usually 
involved leading to incompetence of the valve, another point of distinction from Crohn’s 
disease. 
For better yield, 8-10 colonoscopic biopsies are suggested for histopathology 
(hematoxylin and eosin staining), staining for acid-fast bacteria (Ziehl-Neelsen stain) and 
culture (Lowenstein-Jensen medium or BACTEC method). Biopsies should be taken from 
the edge of the ulcers, some suggest even from the base of the ulcer. However, there is a low 
yield on histopathology because of predominant submucosal involvement. Granulomas have 
been reported in 8-48 percent of patients and caseation in a third (33-38%) of positive cases 
131. The yield of acid-fast bacilli stains has been variable in studies. Culture positivity is not 
related to the presence of granulomas. Endoscopic fine needle aspiration cytology may be 
positive even when the biopsy has been negative156. 
 
Microbiological diagnosis:  
Microbiological diagnosis of ITB may be difficult; the yield of organisms may be low 
because extrapulmonary disease is paucibacillary. Mycobacterial culture should be 
performed in all cases (although results take 6 weeks) because it may be positive even in the 
absence of a characteristic histological picture.  
Radiactive Scintigraphy: 
Gallium 67 citrate is superior to Indium 111-labelled leucocytes for detecting areas of 
tuberculous enteritis157.  
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Immunological tests:  
Chawla et al158 reported that an optical density (OD) of 0.81 on ELISA and 
fluorescent coefficient of 2.56 on soluble antigen fluorescent antibody (SAFA) as cut-off 
gave positivity of 92 and 83 percent, respectively, with 12 and 8 percent false positives 
respectively. Bhargava et al 159 used competitive ELISA with monoclonal antibody against 38 
kD proteins and found a sensitivity of 81 percent, specificity of 88 percent and diagnostic 
accuracy of 84 percent. However, ELISA remains positive even after therapy, the response to 
mycobacteria is variable and its reproducibility is poor. Hence the value of immunological 
tests remains undefined in clinical practice92. 
 
Polymerase Chain Reaction (PCR) analysis:  
The PCR is a unique method of amplifying tiny quantities of DNA and RNA. It is 
ideally suited for diagnosis of conditions in which infective organisms are present in very 
minute quantities to be detected by conventional methods such as staining techniques and 
culture. It has been that PCR can detect as few as 50 organisms per reaction, which is atleast 
a five fold lower limit of detection compared to culture. PCR analysis of the involved 
gastrointestinal mucosa is a useful tool for diagnosis of ITB and it assists in differentiation of 
ITB from Crohn’s disease. Two studies found that the sensitivity, specificity, positive 
predictive value and negative predictive value of PCR assay on tissue specimens in 
differentiating ITB from Crohn’s disease were 21-64.1%, 95-100%, 92-100%, and 28- 
68.2%, respectively160, 161. In a PCR study done on fecal samples of subjects including treated 
and untreated ITB, smear positive pulmonary TB and controls, the sensitivity, specificity, 
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positive predictive value and negative predictive value of fecal PCR were 88.8%, 100%, 
100%, and 93.7%, respectively165. 
Ascitic fluid examination: 
The ascitic fluid in tuberculosis is straw coloured with protein >3g/dl, and total 
cell count of 150-4000/ µl, consisting predominantly of lymphocytes (>70%). The ascites 
to blood glucose ratio is less than 0.9650 and serum ascitic albumin gradient is less than 
1.1 g/dl. 
The yield of organisms on smear and culture is low. Staining for acid-fast bacilli is 
positive in less than 3 percent of cases. A positive culture is obtained in less than 20 
percent of cases, and it takes 6-8 weeks for the mycobacterial colonies to appear. 
However Singh et al167 in an earlier study cultured 1 litre of ascitic fluid after 
centrifugation and obtained 83 per cent culture positivity. Finding an ascitic fluid/blood 
glucose ratio of less than 0.96 may be useful for distinguishing tuberculosis from other 
causes of ascites 166. 
Adenosine deaminase (ADA) is an aminohydrolase that converts adenosine to 
inosine and is thus involved in the catabolism of purine bases. The enzyme activity is 
more in T than in B-lymphocytes, and is proportional to the degree of T cell 
differentiation. ADA is increased in tuberculous ascitic fluid due to the stimulation of T-
cells by mycobacterial antigens. ADA levels were determined in the ascitic fluid of 49 
patients by Dwivedi et al168. The levels in tuberculous ascitis were significantly higher 
than those in cirrhotic or malignant ascitis. Taking a cut off level of 33 U/L, the 
sensitivity, specificity and diagnostic accuracy were 100, 97 and 98 percent 
respectively168. In the study by Bhargava et al169, serum ADA level above 54U/L, ascitic 
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fluid ADA level above 36 U/L and a ascitic fluid to serum ADA ratio > 0. 985 were found 
suggestive of tuberculosis170. In coinfection with HIV the ADA values can be normal or 
low. Falsely high values can occur in malignant ascites. High interferon-γ levels in 
tubercular ascites have been reported to be useful diagnostically171. A cutoff level of 3.2 
U/ml gave the assay a sensitivity of 93% and a specificity of 98%. Combining both ADA 
and interferon estimations may further increase sensitivity and specificity. 
Laparoscopic findings: 
Bhargava et al172 studied 87 patients with high protein ascites, of which 38 were 
diagnosed as having tuberculosis. They found visual appearances to be more helpful (95% 
accurate) than histology, culture or guinea pig inoculation (82.3 and 37.5% sensitivity 
respectively). Caseating granulomas may be found in 85-90 percent of the biopsies. The 
laparoscopic findings in peritoneal tuberculosis can be grouped into 3 categories: 
(i)  Thickened peritoneum with tubercles: Multiple, yellowish white, uniform sized 
(about 4 - 5 mm) tubercles diffusely distributed on the parietal peritoneum. The 
peritoneum is thickened, hyperemic and lacks its usual shiny luster. The omentum, 
liver and spleen can also be studded with tubercles. 
(ii)  Thickened peritoneum without tubercles. 
(iii)  Fibroadhesive peritonitis with markedly thickened peritoneum and multiple thick 
adhesions fixing the viscera. 
Pre-operative diagnosis is difficult even in areas where tuberculosis is common and 
was obtained in only 40% 98 to 50 %173 of patients in India, 33% in Kuwait174 and 25% in 
UK84. Reports of patients who were not diagnosed at life for tuberculosis but were revealed 
at necropsy have been described. This is most commonly seen in the small intestinal 
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strictures, which are not amenable to endoscopic or percutaneous biopsy or fine needle 
aspiration cytology. With advances in endoscopic modalities (enteroscopy), small bowel 
tuberculosis may be diagnosed at earlier stages at present. 
Operative findings are infiltrated thickened and rolled up omentum, increased 
mesenteric fat wrapping the bowel, short and fibrotic strictures and soft to firm hypertrophic 
lesions. The opened specimen may show thickened mucosal fold with ulceration and fibrosis. 
Besides these; ascites, yellow nodules over the visceral and parietal peritoneum (tubercles), 
adhesions, enlarged and calcified mesenteric lymph nodes may be seen. A frozen section 
may help to rule out malignancy. A mesenteric lymph node should always be removed 
because granulomas and caseation are more likely to be found in the nodes than in intestinal 
lesions4, 88. 
Management:  
All patients should receive conventional antitubercular therapy for at least 6 months 
including initial 2 months of rifampicin, isoniazid, pyrazinamide and ethambutol, followed 
by rifampicin and isoniazid for next 4 months. A randomized comparison of 6-month short 
course chemotherapy with a 12 month course of ethambutol and isoniazid (supplemented 
with streptomycin for the initial 2 wks) was conducted by Balasubramanium et al 175 in 193 
adult patients. Cure rate was 99 and 94 percent in patients given short -course and the 12-
month regimen respectively. Kim et al, in a randomized comparison in patients with ITB 
found that 9 months of treatment is as effective as 15 months course of chemotherapy 176. 
Acute-on-chronic intestinal obstruction usually responds to conservative 
management; these patients can be electively investigated and treated accordingly4.   
The surgical treatment of ITB has gone through three phases177. Bypassing the 
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stenosed segment by entero-enterostomy or by ileo-transverse colostomy was practiced 
when effective antitubercular drugs were unavailable, as any resectional surgery was 
considered hazardous in the presence of active disease. This practice however, produced 
blind loop syndrome, and fistulae and recurrent obstruction often occurred in the 
remaining segments. With the advent of more effective antituberculous drugs, various 
reports recommended the use of radical procedures in an attempt to eradicate the disease 
locally. These included right hemicolectomy with or without extensive removal of the 
draining lymph nodes and wide bowel resections. These procedures were often not 
tolerated well by the malnourished patient. Moreover the lesions are often widely spaced 
and not suitable for resection. 
The recommended surgical procedures today are conservative; tuberculosis is a 
systemic disease and cannot be eradicated by surgery alone. A period of pre operative 
drug therapy is controversial .A segment of bowel bearing multiple strictures or a single 
long tubular stricture or with almost complete obstruction may merit resection. Resection 
is segmental with a 5 cm margin. 
Tubercular perforations are usually ileal and are associated with distal strictures. 
Resection and anastomosis is preferred as simple closure of the lesions is associated with 
a high incidence of leak and fistula formation. Two reports suggest that obstructing 
intestinal lesions may relieve with antitubercular drugs alone without surgery. Anand et al 
179 reported clinical and radiological resolution of tuberculous strictures with drug therapy 
even in patients with subacute intestinal obstruction. They treated 39 patients with 
obstructive symptoms using medical therapy. At the end of one year 91 percent showed 
clinical improvement, 70 percent had complete radiological resolution and surgery was 
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needed in only 3 cases (8%). Predictors of need for surgery were long strictures (>12 cm) 
and multiple areas of involvement 179. Balasubramaniam et al 170 made similar 
observations. The mean time required for the relief of obstructive symptoms was 6 
months, although systemic symptoms improved within 2 months. 
Postoperative complications include anastomotic leak resulting in a fecal fistula, 
peritonitis and intra-abdominal sepsis, persistent obstruction, wound infection and 
dehiscence4. Re-operation may be required during the follow-up for recurrent obstruction 
due to strictures or adhesions 84, 97. 
Mortality rate due to ITB ranges from 4-12 % 20, 97, 98,181 is partly due to the 
associated malnutrition, anemia and hypoalbuminaemia. Mortality may be higher (12-
25%) 4, 97 in the presence of acute complications. Delayed diagnosis and injudicious 
treatment due either to limited experience and poor understanding of the disease are 
responsible for mortality.  
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AIMS OF THE STUDY: 
To perform a case control study in patients with intestinal tuberculosis and with matched 
healthy controls in order:  
1. To identify the prevalence of specific risk factors such as diabetes mellitus, HIV 
infection, family history of tuberculosis, history of BCG vaccination, in patients with 
intestinal tuberculosis compared to age- and sex-matched control subjects. 
2. To determine whether there are specific associations of intestinal tuberculosis with 
factors connected with childhood hygiene, as well as a history of treatment for intestinal 
parasitic infections. 
3. To determine the frequency of interferon- gamma (IFN-γ) polymorphisms in patients 
with intestinal tuberculosis compared to appropriately matched healthy controls. 
4. To study the clinical and investigation profile of intestinal tuberculosis in our institution 
from March 2004 to July 2006. 
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METHODOLOGY: 
SUBJECTS: 
Patients: 
Confirmed intestinal tuberculosis patients included those who had their diagnosis 
confirmed by colonoscopic biopsies demonstrating caseating granulomas, AFB on smear, or 
AFB on culture, as well as surgical patients who had surgical resection with a histological 
diagnosis of tuberculosis made on the resected specimen.  
Presumptive intestinal tuberculosis included those patients whose colonoscopic 
biopsies showed granulomatous or nongranulomatous chronic inflammation of colon or 
ileum, with or without extra intestinal tuberculosis, and response to anti-tuberculous therapy.  
Controls: 
Controls included patients with irritable bowel syndrome, acid peptic disease and 
non-ulcer dyspepsia who were matched for age, sex and geographical region with no history 
of pulmonary or extra pulmonary TB in the past, in the family or even in the close contacts. 
These subjects were used for risk factor analysis.  
Healthy elderly controls matched for sex and region were used to analyze frequency 
of interferon–gamma polymorphisms in the general population.  
METHODS:  
Informed written consent was obtained. A detailed questionnaire including risk 
factors of intestinal tuberculosis were provided to the patient and controls and all the 
responses were recorded as given by the patient, and these were maintained in a file. 
Questionnaire for risk factors concerned with hygiene were demarcated as “during 
childhood” and “current”. These included residence in village or town, water source for the 
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household, and availability of toilets. Questionnaire also probed other risk factors like 
diabetes mellitus, HIV infection, and family history of tuberculosis, history of BCG 
vaccination, and history of treatment for intestinal parasitic infections. These responses were 
later entered into a computer for analysis. Relative risks for each of these factors were 
evaluated .All subjects were investigated as clinically necessary.  Clinical and investigation 
profile of intestinal tuberculosis (ITB) was also analyzed. The questionnaire is provided in 
the Appendix to this thesis. 
A 10 ml sample of blood was drawn by one of the laboratory co-investigators into 
Vacutainers. DNA was immediately isolated from the whole blood and stored at -20°C 
pending analysis. Analysis of IFN- γ polymorphisms was done using allele-specific PCR. 
The genotype was analyzed and comparisons made between patients and controls. 
Laboratory analyses 
The IFN-γ (+874 A/T) polymorphism was genotyped using allele-specific PCR as 
described by Lopez-Maderuelo et al 64. Genomic DNA was amplified in two different PCRs 
for each polymorphism; each reaction has a generic antisense primer and one of the allele-
specific sense primers. One internal control, human growth hormone, was amplified in all the 
reaction tubes to assess the success of PCR amplification. The amplified PCR products were 
resolved on 2% agarose gel, stained with ethidium bromide, and documented using a gel 
documentation system. PCR was performed under the following conditions: initial 
denaturation at 94°C for 5 minutes; 40 cycles of 94°C for 30 seconds, 50°C for 30 seconds 
and 72°C for 30 seconds, and final extension at 72°C for 5 minutes.  
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DNA extraction and mutation analysis was as follows 
For DNA extraction the materials required were: 
 
EDTA coated vacutainer tube, centrifuge, plastic Pasteur pipette (sterile), 15ml of self 
standing centrifuge tube (sterile), RBC lysis buffer, WBC lysis buffer, Proteinase K, 10% 
Sodium Dodecyl Sulphate (SDS), saturated NaCl, absolute alcohol, Eppendorf tubes (sterile), 
70 % ethanol, Tris-EDTA (TE) buffer.  
 
Reagents were prepared in the following manner: 
RBC lysis buffer: Dissolve 8.725g of ammonium chloride and 1 g of potassium 
bicarbonate in 1 liter of water. Check the pH and that should be 7.4. Sterilize the solution by 
autoclaving and store it at room temperature for a period of 1year. 
WBC lysis buffer: Mix 25ml of 0.5M EDTA and 2.19 g of NaCl in 250ml of water 
and adjust the pH to 8.0 and make the volume to 500ml with water. Sterilize by autoclaving 
and store it at room temperature for 3 months. 
TE buffer (10mM Tris & 0.1mM EDTA): Mix 1ml of 1M Tris (pH 8.0) and 400 l 
of 0.25 M EDTA (pH 8.0) and make up the volume to 100ml with water. Sterilize by 
autoclaving and store in at room temperature for 1 year. 
10% SDS: Dissolve 10g of SDS in 100ml of water and heat the solution at 65ºC to 
assist dissolution. Sterilization is not required and store in at room temperature for 6 months. 
Proteinase K: Dissolve the lyophilized Proteinase K (Cat no. PK1, Bangalore Genie) 
in 10ml of sterile water to obtain a concentration of 10mg/ml. Aliquot 500 µl volume into 
Eppendorf tubes and store at -200C for a long period.  
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Saturated NaCl: Dissolve 36.05g of NaCl in 100ml of water and saturate or 6M NaCl 
solution.  Sterilize by autoclaving and store in at room temperature for 1 year.      
Procedure: Collect blood in EDTA-coated vacutainer tube. Centrifuge the sample at 
400rpm for 15min. Three layers will be visible, the top yellow layer is plasma, the middle 
white layer is buffy coat and the bottom red layer is erythrocytes. The plasma is carefully 
removed and discarded and buffy coat collected in fresh tube. Ten volumes of RBC lysis 
buffer is added and incubated at room temperature for 10 minutes. Later the tube is 
centrifuged at 4000rpm for 10min. The supernatant is discarded and a white pellet will be 
seen. This is repeated till a clear white pellet is obtained. Add 4.5ml of WBC lysis buffer to 
the pellet to make a homogenous solution. Add 250µl of 10% of SDS and 100µl of 
Proteinase K to this solution mix them well and incubate at 37°C for overnight or at 55°C for 
two hours. Check the lysis, if the lysis is not complete, then add 50µl of Proteinase K and 
continue the digestion. When the lysis is complete, add 1.5ml of saturated NaCl solution and 
mix well till the solution turns milky white. Centrifuge this solution at 4000rpm for 15min 
and collect the supernatant in a fresh tube. To the supernatant add two volumes of absolute 
ethanol and mix gently, a white thread like structure will be seen which reaches the top of the 
solution. Collect this thread like structure is in a fresh Eppendorf tube containing 1ml of 70% 
ethanol, using a sterile pipette tip. Tap the tube very well to remove the excess salt adhering 
to the precipitate. Remove the precipitate using a pipette tip and air-dry it. When the 
precipitate turns transparent, transfer it into an Eppendorf tube containing 200-300 µl of TE 
buffer. Dissolve the DNA by incubating at 37°C for 2 hour or 65°C for 30minutes and store 
in deep freezer (-20°C) for long -term storage or in the fridge for short term. 
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PCR analysis was done using the primers used in the study by Lopez et al. Primers 
(sense) used for IFN –gamma A and IFN-gamma T alleles were 5’- ttc tta caa cac aaa atc aaa 
tca-3’ and 5’-ttc tta caa cac aaa atc aaa tct - 3’ respectively with polymerized gene product 
size of 261bp. Sense and antisense primers used for internal controls were 5’-gcc ttc caa cca 
ttc cct ta-3’ and 5’-tca cgg att tct gtt gtg ttt c-3’ respectively.  
 
Sample size:  
Using appropriate equations, we calculated a sample size of 100 with 50 each in 
intestinal tuberculosis and control group which was required to study the association between 
IFN-γ polymorphisms and intestinal tuberculosis with an Odds ratio of 3.5, with 80% power 
at 5% level of significance, the event rate in control being taken as 36.7%. 
 
Statistical analyses: 
For statistical analysis we used the SPSS (version 11). For each of the parameters that 
are included, relative risks and their confidence intervals were calculated between patients 
and controls. Significance of the association was calculated using the Chi square test and P 
value of < 0.05 was considered statistically significant 
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RESULTS  
 
Demographic characteristics of the subjects 
 
a.  Intestinal tuberculosis patients: 
The mean age of these patients was 35.56 years, and ranged from 15 years to 61 
years. 20 of the patients were females and 30 were males. The age and sex distribution is 
shown in Table I. 
Table I. Distribution of ITB patients by age and sex: 
 
Age (years) Male Female 
11-20 3 3 
21-30 7 7 
31-40 8 4 
41-50 7 2 
51-60 4 4 
61-70 1 0 
 
50 healthy age- and sex-matched controls were studied for the epidemiologic 
associations with hygiene and other behaviors. Their ages ranged from 17 years to 61 years 
(mean 36.38 years). 20 of these were females and 30 were males. 
In addition, 50 elderly sex- and region-matched control subjects were studied in order 
to determine associations of ITB with genetic polymorphisms. 20 were females and 30 were 
males. Their ages ranged from 60 years to 81 years (mean age 63.5 years). 
 
Epidemiological associations and risk factors:  
 
a.  Place of residence, domestic water supply and toilet availability: These are all  
factors that determine the level of domestic hygiene. Specific infections such as helminth  
infections (associated with less domestic hygiene) have been postulated to be associated with  
higher incidence of clinical tuberculosis; hence these factors were examined. 
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Table II. Putative factors associated with hygiene and their association with ITB. 
 
Risk factors ITB Controls P value RR 95%CI 
Childhood residence 
Village 
Town 
City 
             
16            
32 
2 
                  
31                   
11 
8 
 
0.0048@ 
 
0.51 
 
 
0.32-0.81 
Current residence 
Village  
Town 
City 
 
14 
33 
3 
 
18 
22 
10 
 
0.52@ 
 
0.77 
 
0.436-1.38 
Childhood water source 
Piped water 
Tube well 
Others  
 
34 
12 
4 
 
5 
28 
17 
 
0.0001# 
 
6.8 
 
2.8-15.9 
Current water 
Piped water 
Tube well 
Others  
 
40 
10 
0 
 
16 
24 
10 
 
0.0001# 
 
2.5 
 
1.13-3.83 
Childhood toilet 
None  
Shared 
One/more  
 
11 
3 
36 
 
26 
5 
19 
 
0.0035$ 
 
0.42 
 
0.23-0.76 
Current toilet availability 
None 
Shared 
One/more 
 
3 
3 
44 
 
8 
5 
37 
 
0.124$ 
 
0.46 
 
0.19-1.11 
 
@Town and city grouped together and Fisher exact test done to compare residence in village 
with residence in town/city. #“Tubewell” and “other” grouped together and Fisher exact test 
done comparing against Piped water availability.  $“None” and “shared” grouped together 
and Fisher exact test done comparing against “One or more toilets in house”.  
This study revealed that factors associated with increased domestic hygiene levels 
either during childhood or currently were apparently positively associated with a diagnosis of 
ITB. Thus, residence in a village in childhood was protective for ITB (RR 0.51, 95% CI 
0.32-0.81), while current residence in a village was not protective. Availability of piped 
water in the household during childhood was a significant risk factor (RR 6.8, CI 2.8-15.9), 
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while piped water availability currently was also a risk factor (RR 2.5, CI 1.13-3.83) for ITB. 
Similarly, non-availability of individual toilets in the household during childhood was 
protective for ITB (RR 0.42, CI 0.23-0.76). [Table II]. 
b. Other risk factors:  
In this study, there was no significant difference between the groups for other 
socioeconomic and risk factors including education, immunosuppression, alcohol, smoking, 
BCG vaccination, and anti-helminth treatment (Table III). 
Table III. Risk factors that could be associated with ITB 
 
Risk factors 
 
ITB % (n=50) Control % (n=50) P value 
Education 100 94 0.665 
Past history of TB 10 0 0.022 
Family history of TB 8 0 0.041 
Immunosuppressive therapy 2 0 0.315 
High risk behaviour 0 0 0 
Alcohol use 14 10 0.538 
Smoking 12 8 0.505 
BCG vaccination 98 98 1 
Treatment of intestinal parasites 36 36 1 
 
c. Interferon-gamma polymorphisms: 
 
As shown in Table IV and depicted in figure 1, most of the patients as well as the controls 
were heterozygous for the IFN-γ polymorphisms.  No significant difference was noted 
between the two groups. 
 
Table IV. Frequency of IFN – gamma polymorphisms among ITB patients and healthy 
controls.  
 
Subjects IFN – gamma (+ 874 A/T genotypes) 
          AA (%)                      TA (%)                     TT (%) 
ITB 0 50 0 
Age matched healthy Controls 0 50 0 
Elderly controls 0 50 0 
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                                                             Figure 1. 
 
 
The above picture shows some of the PCR products of the patients and controls (A & C and B & 
D) respectively. The bands (i.e., PCR products mounted on 2% agarose gel) are seen in both the 
groups suggesting that the patients and controls have both A allele and T allele i.e., patients and 
controls are heterozygous for interferon – gamma (+ 874 A/T) polymorphisms.  
 
 
 
 
 
 
 
 
PCR for Interferon gamma (+ 874A allele) 
PCR for Interferon gamma (+ 874T allele) 
  Panel A  
Panel B 
Panel C Panel D 
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Clinical features 
 
1.  Location of disease:  
 
Table V shows the disease location by sex of patient in the 50 patients with ITB.  When 
examined according to site of disease involvement, the largest single group among males and 
females had ileo-colonic involvement (12/30 - 40 % and 9/20 – 45%). There was a trend towards 
higher involvement of ileo-cecal among males (8/9) and colonic involvement among female  
(6 /10) patients. 
Table V. Location of disease in ITB. 
 
Location Male Female 
Esophagus 1 0 
Stomach and Duodenum 0 1 
Ileum 5 2 
Ileocecal 8 1 
Ileocolonic 12 9 
Colonic 4 6 
Others 0 1 
Total 30 20 
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2. Clinical presentation of ITB:  
 
Figure 2, shows the clinical presentation of 50 ITB patients: Abdominal pain was the most  
 
common clinical presentation (80%). 
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Figure 2: Clinical presentation of intestinal tuberculosis 
 
 
Table VI shows location of disease (small bowel and colonic) in relation to presentation.  
 
Abdominal pain was uniformly distributed.Bleeding per rectum as evidenced by malena /  
 
maroon colored stools was more common  in ileal involvement alone or with adjacent  
 
colonic involvement compared to segmental colonic involvement.   
 
Chronic diarrhea was common in patients with colonic involvement (40%- 8 % of  
 
total  cases) compared to Ileocolonic (30% - 18 % of total cases) or ileal involvement (0).   
 
Subacute intestinal obstruction was common in ileo-colonic involvement (23%). 
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Table VI: Location of disease (small bowel and colonic) in relation to presentation. 
 Presentation 
 
Location 
Ileum and small 
bowel n = 7 
Ileo-colonic 
n= 30 
Colonic 
n = 10 
Fever 3 13 6 
Abdominal pain 7 23 9 
Vomiting 2 13 2 
Diarrhea 0 9 4 
Bleeding per rectum 3 5 0 
Abdominal lump 2 2 0 
Weight loss 5 21 8 
Subacute intestinal obstruction 1 7 0 
Anorexia  1 12 5 
 
One patient each with esophageal involvement presented with fever, weight loss and 
dysphagia, gastro duodenal involvement presented with features of gastric outlet obstruction and 
weight loss; duodeno-colonic involvement with abdominal pain, diarrhea and weight loss. 
Mean duration of symptoms: 1.4 years. 
3. Physical findings in intestinal tuberculosis:  
 
      Figure 3, shows physical findings in 50 ITB patients. Fever was the most common  
 
general finding (56%).Palpable mass was the most common per abdominal finding( 28%).  
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                   Figure 3: Physical findings in intestinal tuberculosis. 
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4. Radiological findings in ITB:  
 
Table VII shows radiological findings (USG abdomen and CT abdomen) in 50 ITB  
 
patients.  Radiological findings were nonspecific and bowel wall thickening is the most common  
 
finding in both the modalities (45% and 100%) respectively. 
 
Table VII: radiological findings in intestinal tuberculosis:  
 
Abnormalities USG abdomen 
% (n=31) 
CT abdomen 
% (n=6) 
Bowel wall thickening 45 100 
Omental thickening 16 33 
Mesenteric LN 35 66 
Ascites 16 0 
 
5. Endoscopic findings in ITB:  
 
Table VIII shows endoscopic findings in 50 ITB patients. Ulcerations and nodularity  
 
were most  common findings. 
 
Table VIII: Endoscopic findings in 50 ITB patients 
 
Colonoscopic findings 
 
Ileal or small 
bowel % (n= 4) 
Ileocolonic     
%   (n=30) 
Colonic         
% (n=10) 
Ulcers 75  70  80  
Nodularity 50 83 70 
Skip lesions 0 20  0 
Stricture 0 9 60 
Deformed ileo-cecal valve 0 50  0 
Cobblestone  0 3 0 
Normal 0 0 10 
Pseudopolyps 0 3 10 
Growth  0 0 20 
 
Colonoscopy   was normal in one patient who was on immunosuppressants (leflunomide) 
for rheumatoid arthritis and diagnosis was made on segmental biopsies. (Confluent granulomas 
were seen and repeat biopsies on follow up after 9 months of treatment were normal). 
Terminal ileum had ulcerations or nodularity in 46.5% of ileo-colonic involvement.  
 
Hence terminal ileal involvement was seen in 36% of the total cases and only caecal involvement  
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in 4% of total cases. Combined ileocecal lesions were seen in 18% of the patients. Ileo-cecal  
 
valve was deformed ( stenosed or patulous ) in 50% of  cases with ileo-colonic involvement. 
 
Esophagus was involved in 2% of the cases. This patient had dysphagia and a 
midoesophageal ulcer on endoscopy, biopsy revealed granuloma. There was no evidence of 
pulmonary involvement.Gastro duodenal involvement was seen in 2% of cases. This patient had 
features of gastric outlet obstruction with large ulcers and nodularity in stomach and duodenum 
causing obstruction at D1-D2 junction. Endoscopic biopsy confirmed tuberculosis on culture.She 
had spontaneous perforation at the fundus of the stomach and underwent laparotomy and 
omental patch closure of gastric perforation with gastrostomy. 
 
6.  Surgical findings 
Surgery was performed in 8 patients.  
Five patients were diagnosed to have TB after surgery, one had presented with 
perforation, three had features of subacute intestinal obstruction (SAIO) and one had chronic 
diarrhoea. Three had ileal ulcers and one each had ileo-colonic and duodeno-colonic 
involvement.  Two patients had undergone colonoscopy, but biopsies were inconclusive. One of 
these patients had duodeno –colonic fistula with granulomas seen in resected bowel and 
mesenteric lymph node. Two lesions in colon appeared like malignant growths causing luminal 
compromise. 
36% had extra-luminal involvement with omental thickening and / or mesenteric 
lymphadenopathy in (12%), disseminated tuberculosis (20%) with tuberculous cervical 
lymphadenitis (6%), pulmonary involvement in 12% i.e., bronchial involvement (2%), pleural 
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effusion (4%) and parenchyma in 6%; hepatic and thoracic spine involvement in 2% each of 
cases. 
11 / 41 patients (26.8%) of the cases had pulmonary involvement with active TB in 12.2 
% and healed TB in 14.6%. 
Hemoglobin was < 8 in 9 patients and > 8 and < 10 gm/dl in 9 patients i.e., <10gm/dl in 
18 patients.  
26/ 48 patients had hypoalbuminaemia (< 3.5 g/dl). Serum albumin was <2.5g/dl in 14 
patients and <1.5g/dl in 2 patients respectively. 12 patients had only hypoalbuminaemia without 
significant anemia (serum albumin < 3.5 g/dl and Hemoglobin > 10 gm/dl). 
Table IX correlates hypoalbuminaemia with disease location. As shown in the table, there 
is no significant difference between different locations. 
 Table IX: Hypoalbuminemia and disease location:  
Location Number of patients with serum albumin 
< 2.5gm/dl 
Small bowel / ileal 2 
Ileo-colonic 6 
Colonic  5 
Others 1 
 
7.   Histopathology:  
 
ITB was confirmed in 80% of the cases and was probable in 20 % of cases. 
Granulomas were found in 76 % of cases, with caseation in 28% and confluent in 48 %. 
AFB was seen on smear in 28 % of biopsy specimens. Chronic nonspecific colitis was seen in 20 
% of cases. 
 54
8.   Microbiological findings 
AFB smear and culture were positive in 41.3% (19/46 cases- 18 were culture positive and 
2 were smear positive) of the cases where biopsy specimens were sent for microbiological study. 
Biopsy specimen was not sent for microbiologic study in 4 (8 %) patients. Smear was positive in 
2 cases and was helpful in diagnosing in one case where culture was negative. 
AFB smears and / or culture was thus helpful in making the diagnosis in 5 (10 %) of the 
patients where histopathology was inconclusive. 
Stool PCR for AFB was positive in 11/ 13 patients out of which 4 had features of healed 
TB on chest X-ray. None of them had active pulmonary tuberculosis. 
9.   Response to treatment:  
Most (70%) of our patients had 9 months of treatment, 6 months in 24% and 12 months 
in 6 %. 
40% were cured of the disease, 34 % were still under treatment and 26 % had lost to 
follow up. 
        Figure 4, shows complications of ITB like SAIO, perforation, bleeding and fistula were  
 
seen in 20%, 8%, 4 % and 2 % respectively. One of the patients had bleeding while on treatment  
 
and other had it 2 weeks after surgery with ulcers at the anastomotic site which responded to  
 
conservative treatment. 
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Figure 4: complications in intestinal tuberculosis. 
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DISCUSSION:  
Tuberculosis is common in developing countries. Poor socio-economic status, poor 
sanitation and the recent upsurge of HIV infection are thought to enhance the susceptibility to 
tuberculosis in India. Although pulmonary tuberculosis is very common, intestinal tuberculosis 
accounts for only a small proportion of the total cases of tuberculosis. The risk factors for 
intestinal tuberculosis (ITB) are not known. In addition, there is now increasing incidence of 
Crohn’s disease, the other granulomatous bowel disease that mimics tuberculosis. In Crohn’s 
disease, it is thought that hygiene status in childhood is responsible for the emergence of 
intestinal inflammation. Thus, Gent et al found that Crohn’s disease was more common in 
subjects whose first houses had a hot-water tap and separate bathroom188. This connection 
between Crohn’s disease and better hygiene in childhood is ascribed to an effect of 
gastrointestinal infection on immune conditioning of the gastrointestinal tract. The relationship 
between intestinal tuberculosis and childhood hygiene is not known. It is commonly considered 
that tuberculosis is more rampant where the level of domestic hygiene is less. Surprisingly, the 
present study found that parameters like living in a village during childhood, lack of piped 
drinking water in childhood and lack of toilet facilities in childhood - all of which reflect poor 
childhood hygiene – actually appeared to be protective against ITB. These findings suggest that 
immune conditioning by gastrointestinal infections during childhood may protect against the 
development of ITB. 
Studies done by Bentwich Z et al 65 and Elias D et al 66 suggested that there was a strong 
positive association between TB and intestinal helminth infection.  Helminths are usually found 
to activate Th2-type immune responses and to down-regulate Th1-type responses. The latter are 
responsible for production of interferon-gamma which is usually considered essential for 
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containment of tuberculous infection. However, the present study did not find any significant 
association between intestinal helminth infection or treatment for parasites and the occurrence of 
intestinal tuberculosis. 
There is some evidence that host genetic factors play a role in susceptibility to 
tuberculosis. Kallmann and Reisner28 found an appreciably high concordance of pulmonary TB 
in monozygotic compared to dizygotic twins. Humans defective in genes for IFN-gamma or the 
IFN-gamma receptor are prone to serious mycobacterial infections, including tuberculosis 37, 38. 
Dolores Lopez et al 64and Manada Rossow et al39 found that polymorphisms in the gene for IFN-
gamma (+ 874 A/T) were associated with increased risk of pulmonary tuberculosis in Spanish 
and Cambodian population respectively. In a study, IFN-gamma production was most severely 
depressed in patients with moderately advanced and far advanced pulmonary disease suggesting 
functional significance of genetic polymorphisms in these cytokines 43. In our study there was a 
high level of heterozygosity for IFN-gamma gene polymorphisms in the community and the 
prevalence of these polymorphisms did not significantly differ in ITB. Although this was a small 
study in terms of numbers of patients studied, this suggests lack of a major role for IFN-gamma 
gene polymorphisms in the development of ITB in Indians. It is possible that other genetic 
factors or environmental factors may play a predominant role in genesis of ITB. 
Though HIV was screened in 80% of the cases, none of the patients was seropositive. 
13% and 16.6% of the patients with gastrointestinal tuberculosis in two series from India had 
HIV infection 182,183. Low rates of HIV positivity in India among gastrointestinal tuberculosis 
cases probably reflect the high endemicity of TB even without HIV infection. 
Age at presentation ranged from 15 to 61 years, highlighting the fact that no adult age 
group is immune to intestinal tuberculosis. The maximum number of cases, however, was seen in 
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the younger age group 21-40 years (52 % of cases) with a mean age of 35.56 years. These results 
are similar to other Indian studies 96,131,182. The mean age was slightly lower than the mean age of 
40 years reported by Chang et al from Taiwan 191.This may be attributed to the higher prevalence 
of and the earlier age of exposure to TB in our country. 
There was slight preponderance of male sex ( M:F = 3:2 ) which is in accordance with 
other studies131,182.This may be due to the fact that males have more access to the health system 
in India compared to females. Earlier workers have observed the disease with variable female96 
preponderance. 
Abdominal pain, weight loss and fever were the most common clinical presentation 
(80%, 46% and 74 % respectively) and abdominal mass (28 %) was the most common clinical 
finding. Almost similar findings were seen in other studies131, 137,182,184,189. As in our study, none 
of the clinical features were pathognomonic of ITB. Weight loss could be the result of 
catabolism subsequent to infection, malabsorption secondary to small bowel overgrowth, 
increased bile salt losses from ileum, and post prandial abdominal discomfort137.Most of the 
patients with bleeding (87%) had ulcerations in ileal (50%) and ileo-colonic areas (37%). In a 
study96, bleeding due to ulceronodular lesions in ileo-cecal region was noted in only 4% of cases. 
Ileo-colonic i.e., ileum with contiguous colonic involvement including cecum (60 %) was 
the most common site of involvement in our study.  In a study by Kyoung Mee Kim et al192, ileo-
colonic involvement was seen in 55% of the cases.  Ileocecum was involved in 18 % of the cases 
as compared to other studies with 20 % 182, 31 % 131, 42% 80. The predilection of the bacillus for 
the ileo-cecum is mainly attributed to three factors: 1) relative physiologic stasis in the area 2) 
the high rate of absorption with more complete digestion; and 3) the abundance of lymphoid 
tissue in ileocecal region.   
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Oesophageal, gastroduodenal and duodeno-colonic involvement was seen in one patient 
each (2% each). The higher incidence of small intestinal TB in previous studies was probably 
due to inclusion of reports from surgical series and presumptive diagnosis based on radiological 
studies of small bowel series .The low incidence of small bowel involvement in our study could 
be due to the fact that endoscopic confirmation (histopathological and microbiological) at sites 
other than small bowel did not warrant further evaluation of small bowel. These were similar to 
the findings in recent studies 80,182. 
Radiological findings were non-specific. The results obtained on CT scans are 
comparable to USG findings in other studies182. Ileocecal valve was deformed in 30% of the total 
cases and ITB was confirmed in 80% of these findings. In a retrospective study182, ileocecal 
valve was abnormal in 20% of the cases and all of them were found to have TB on basis of 
histopathologic or microbiologic methods. . 
Endoscopic features of ITB are also not pathognomonic, and so required confirmation by 
biopsy. Common colonoscopic findings were ulcers (68%), nodularity (68%), skip lesions 
(15%), deformed ileo-cecal valve (30%), stricture (20%), mass like appearance (4%), 
pseudopolyps in 2% and cobblestone appearance in 2%. In other studies the findings included 
ulcers (28-92%), nodularity(56-80%), deformed ileo-cecal valve (40-55%), stricture (12-
27.5%)131,160,189,192, pseudopolyps (70%)160  One patient had normal colonoscopy but segmental 
biopsy revealed granulomas which responded to a course of ATT as evidenced by normal 
colonoscopy and biopsy on follow up.  Mishra et al 190, in a series of 130 patients with colonic 
TB, suggested that dilatation of colonic stricture was helpful in detecting the abnormalities in 
proximal colon and terminal ileum and in confirming the diagnosis of ITB in 50 % of patients 
with colonic stricture. 
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ITB was confirmed in 80% of the cases and were probable in 20% of cases. In a 
retrospective series of 260 cases, 66.5% of GITB were confirmed and 29.6% were probable TB. 
Confirmed diagnosis was obtained in 100% of cases occurring in the upper gastrointestinal tract, 
66% of cases in the ileocecal region/colon and 40% of cases that had small bowel involvement182 
In a series from Lancashire, UK, a 94% confirmation was achieved in cases of abdominal 
TB84.The high percentage of use of surgical technique and necropsy diagnosis in both series 
from a nonendemic areas are the reasons for high rate of confirmed diagnosis. 
Granuloma was found in 76 % of cases with caseation in 28% and confluent granulomas 
in 48 %. AFB was seen in 28 % of biopsy specimens. Chronic nonspecific colitis was seen in 20 
% of cases. In series from Singh et al 131, Nikhil at al 182 and Alvares et al184 caseating 
granulomas were seen in 19%, 61%, 66% of cases and AFB staining in 0, 5%, 15.6%  cases. 
Chronic colonic inflammation was seen in 30% of Alvares’s series184. In our study, the yield 
from ulcers were higher because the biopsy material was subjected to microbiology (smear and 
culture), in addition to histological studies which was also the reason in other studies182.  
AFB smears and/or culture was positive in 41.3% (38% of total cases) of the biopsy 
specimens sent for microbiological analysis (19/46). Smear was positive in 2 cases and was 
helpful in diagnosing in one case where culture was negative. The yield of positive cultures was 
seen to be greater in tissue with caseation necrosis, though organisms were also recovered from 
tissues showing non-caseating granuloma and non-specific inflammation. The intestinal tissue 
gave more positive cultures (41%) than did lymph nodes (14%). Vij et al 17 and Bhargava et al130, 
reported positive cultures in 40% of endoscopy biopsy specimens although acid-fast bacilli were 
not seen in any of the endoscopy specimens of the first series.  Hence routine culture of biopsy 
tissue increases the diagnostic yield. In a series by Shah et al137, none of them were culture 
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positive. In the present study, AFB smears and / or culture was helpful in making the diagnosis 
in 5 patients where histopathology was inconclusive. A combination of histology and culture of 
the biopsy material can be expected to establish the diagnosis in over 60-80 percent of cases137, 
153. Stool PCR for AFB was positive in 11/13 patients out of which 4 had features of healed TB 
on chest X-ray. None of them had active pulmonary tuberculosis. 
36% had extra-luminal involvement with omental thickening and / or mesenteric 
lymphadenopathy in ( 12% ) , disseminated tuberculosis (20% ) with tuberculous cervical 
lymphadenitis ( 6% ) , pulmonary involvement in 12% i.e., bronchial involvement (2%), pleural 
effusion ( 4% ) and parenchyma  in ( 6% );  hepatic and thoracic spine  involvement in 2% each 
of cases. 11 / 41 patients (26.8%) of the cases had pulmonary involvement with active TB in 12.2 
% and healed TB in 14.6%. This is in comparison with other studies22. 
 8 patients ( 16 % ) underwent surgery  and was diagnostic 5 ( 10 % )  , therapeutic 3 ( 6 
% ) , diagnostic and therapeutic in 5 ( 10 % ) cases . In our study, lower incidence of surgical 
modality as a diagnostic procedure may be due to the higher yield of colonoscopic biopsies. 
Complications like subacute intestinal obstruction, perforation, bleeding and fistula were 
seen in 20%, 8 %, 4 % and 2 % respectively while on treatment. Subacute intestinal obstruction 
was managed conservatively in one and the other underwent ileal stricturoplasty and limited 
right hemicolectomy. Two patients had bleeding, one from the ulcers in ileum and other at the 
ileo-colonic anastomotic site 2 weeks after right hemi-colectomy done elsewhere. Both were 
managed conservatively and blood transfusions were required in the second patient. Three 
patients had perforations, two were ileal and one was from stomach. One patient had multiple 
ileal perforations (4 in number) and he underwent resection of the involved ileal segment and 
ileostomy with plan for ileostomy closure at a later date.  Other patient with ileal perforation 
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underwent omental patch closure of the perforation with  ileostomy followed by ileostomy 
closure and limited right hemicolectomy for ileo-cecal junction stricture after 2 months.  
Bhansali 4reported that small intestinal strictures were multiple in 71 out of 119 patients; as 
many as 12,16 and 19 strictures have been reported in a single patient. One patient in our study 
with gastric perforation underwent omental patch closure of the perforation with feeding 
gastrostomy.One patient with fistula underwent left hemicolectomy and end colostomy with 
repair of duodeno-colonic fistula. In a study by Prakash et al20; out of 300 patients with ITB 
between 1959 to 1977, there was a transition from radical hemicolectomy, performed in initial 
107 patients, to limited ileo-colonic resection in 88 later patients. Pujari et al 177 suggested that  
strictures which  reduce the lumen by half or more and which cause proximal hypertrophy or 
dilation needs to be  treated by strictureplasty 177 which involves a 5-6 cm long incision along the 
anti -mesenteric side, which is closed transversely in two layers. Katariya et al 178 reported 
stricturoplasty in pyloroduodenal and ileocecal lesions. 
Out of the 8 patients who had undergone surgery, caseating granulomas were seen in all 
specimens with mesenteric lymphnodes and AFB bacilli were seen in two of the lymph nodes. 
Hoon et al37, suggested that caseating granulomas are frequently seen in mesenteric lymph nodes 
even though they are absent in intestinal specimens. This is most commonly seen if the patient is 
on anti-tubercular treatment. 
Most (70%) of our patients are on 9 months , 24% on 6 months  and 6% on12 months of 
treatment. Two studies done earlier have shown that short course treatment is as effective as long 
term treatment 175,176.  
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CONCLUSIONS  
1. A case-control study showed that several factors concerned with domestic 
hygiene during childhood were strongly associated with a diagnosis of intestinal 
tuberculosis. These included: 
a. Living in a town or city (versus a village) during childhood 
b. Availability of piped drinking water in childhood 
c. Presence of toilets in the house in childhood 
These findings suggest that immune conditioning of the gastrointestinal tract 
during childhood by poor domestic hygiene may protect against intestinal 
tuberculosis. 
2. There was high level of heterozygosity for IFN-gamma polymophisms in the 
community, and the prevalence of these polymorphisms did not significantly 
differ in ITB. 
3. In this small series, the usual risk factors for intestinal tuberculosis, including HIV 
infection, were not detected. 
4. Male:Female ratio was 3:2 i.e., male predominance. 
5. Mean age of presentation was 35.56 years. 
6. Abdominal pain was the most common clinical presentation and abdominal mass 
was the most common clinical finding. 
7. Disease distribution was oesophageal (2%), gastroduodenal (2%), duodeno-
colonic (2%), ileal (14%), ileocolonic (including ileocecal) in 60 % and colonic in 
20%.   
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8. Colonoscopic ulcers and nodularity were most common findings. Yield of 
colonoscopic specimens in diagnosis was high. 
9. Diagnosis was confirmed in 80% of the cases using histopathological and 
microbiologial methods.  
10. Surgery was infrequently needed, mainly to treat complications. 
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Case report form 
 
RISK FACTORS FOR INTESTINAL TUBERCULOSIS 
 
Name  :                                       Age  :                        Sex:  M / F 
Hosp.No. :                                              Occupation ; 
D.O.B.  :                                                         
Address : 
 
 
District and state of residence: 
 
Tel.  : 
E-mail  :  
Religion :  Hindu           Christian           Muslim           Others (specify)  
 
 Age 0-5 Current 
Village Village 
Town Town 
City City 
Area of residence 
Urban slum Urban slum 
Piped water Piped water 
Tube well Tube well 
River  River  
Lake  Lake  
Tank Tank 
Predominant water source 
Others (specify)  Other (specify) 
None in house None in house 
Shared with other families Shared with other families 
Single toilet Single toilet 
Toilet facilities 
Multiple toilets in house Multiple toilets in house 
 
Education: None     I-V Std.       VI-X Std.        +2            Graduate        Postgraduate  
 
Other history: 
Pulmonary or other TB                 No                 Yes (details) 
Diabetes mellitus                            No               Yes (details)  
Immunosuppressive therapy        No                Yes (details)  
Risk behavior                             Never             Occasional      Frequent 
Alcohol use                                    Never              Occasional       Regular     Ex-user 
Smoker                                           Never           Occasional       Regular     Ex-smoker 
Family h/o tuberculosis                 Sibling        Parent              Grandparent   Others 
BCG vaccination                             No                         Yes 
Treatment for intestinal parasites      No                     Yes 
History:                                    Present                   Absent 
 
Fever 
Abdominal pain 
Vomiting 
Diarrhea 
Bleeding PR 
Abdominal lump 
Weight loss 
Acute intestinal obstruction 
 
Clinical Examination: 
 
Pallor 
Icterus 
Pedal edema 
Clubbing 
Lymph nodes 
Ht. (cm) 
Wt. (Kg) 
BMI 
Abdomen: 
  Distension 
      Peristalsis 
      Mass 
      Liver  
      Spleen  
      Ascites  
Other systems   
 
 
Investigations: Only clinically indicated investigations will be done 
 
Hb: 
MCV: 
Retics: 
WBC TC:                                DC: N       L        M         E        B          BF 
Platelets: 
ESR: 
Fasting blood sugar: 
Post-prandial blood sugar: 
S. creatinine: 
Liver function tests: 
HIV: 
Stool occult blood: 
Stool parasite: 
Mantoux  test: 
 
Chest X-Ray: 
 
Ultra sonogram of abdomen: 
 
Barium meal follow through: 
 
CT scan: 
 
Gastroscopy: 
 
Colonoscopy: 
 
Surgical finings: 
 
Biopsy reports: 
 
AFB Culture: 
 
AFB PCR: 
 
Genotyping for IFN-   polymorphism: 
 
Final diagnosis:              Confirmed             Probable              
 
Site of involvement: 
 
Treatment given: 
 
Response to therapy: 
 
Cured     Did not resolve  Still under therapy 
       Therapy is continued  Did not follow up 
 
Duration of treatment (months):   6                   9                  12              DOTS 
 
Complications:    
 
SAIO     Bleeding   Fistula 
         Perforation    Nil 
 
